Kevin Tang - May 8, 2023 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
10%+ Owner
Signature
Kevin Tang
Stock symbol
TCRR
Transactions as of
May 8, 2023
Transactions value $
$163,777
Form type
4
Date filed
5/10/2023, 07:02 PM
Previous filing
May 5, 2023
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRR Common Stock Purchase $111K +57.1K +1.35% $1.95 4.27M May 8, 2023 By LP F1, F2
transaction TCRR Common Stock Purchase $39.3K +20.1K +0.47% $1.95 4.29M May 9, 2023 By LP F2, F3
transaction TCRR Common Stock Purchase $13.2K +6.77K +0.16% $1.95 4.3M May 10, 2023 By LP F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $1.94 to $1.95. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1, 3 and 4 herein.
F2 The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP.
F3 These shares were purchased in multiple transactions at prices ranging from $1.92 to $1.95.
F4 These shares were purchased in multiple transactions at prices ranging from $1.945 to $1.95.